Successful use of Arixtra® in a patient with paroxysmal nocturnal hemoglobinuria, Budd-Chiari syndrome and heparin-induced thrombocytopenia

被引:25
作者
D'Amico, EA [1 ]
Villaça, PR
Gualandro, SFM
Bassitt, RP
Chamone, DAF
机构
[1] Univ Sao Paulo, Fac Med, Hosp Clin 155, AV EC Aguiar,Dept Hematol, Sao Paulo, Brazil
[2] Fundacao Prosangue, Haemoctr Sao Paulo, Sao Paulo, Brazil
关键词
D O I
10.1046/j.1538-7836.2003.0468c.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2452 / 2453
页数:2
相关论文
共 5 条
[1]   How I treat heparin-induced thrombocytopenia and thrombosis [J].
Alving, BM .
BLOOD, 2003, 101 (01) :31-37
[2]   Selective inhibition of coagulation factors: Advances in antithrombotic therapy [J].
Bauer, KA .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 :15-24
[3]   Are patients with paroxysmal nocturnal hemoglobinuria at risk for heparin-induced thrombocytopenia? [J].
Huehn, C ;
Righini, M ;
Starobinski, M ;
Angelillo-Scherrer, A ;
De Moerloose, P .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (02) :389-390
[4]  
PARKER CJ, 1999, CLIN HEMATOLOGY, V1, P1264
[5]   Pentasaccharides [J].
Turpie, AGG .
SEMINARS IN HEMATOLOGY, 2002, 39 (03) :158-171